Japan· JP-1190024M1028
フマル酸ジメチル
A medicinal product containing フマル酸ジメチル, registered in Japan by バイオジェン・ジャパン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- フマル酸ジメチル
- Manufacturer
- バイオジェン・ジャパン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
フマル酸ジメチル in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADIFEMUVipharm S.A., Ożarów Mazowiecki
- PolandAdifemuVipharm S.A.
- IcelandArbicenEGIS Pharmaceuticals PLC
- FinlandBalfumonG.L. Pharma GmbH
- SwedenDimethyl fumarate 1A Farma 120 mg Enterokapsel, hård1A Farma A/S
- NetherlandsDimethylfumaraat Abdi 120 mg maagsapresistente capsules, hardAbdi Farma GmbH
- United Statesdimethyl fumarateGolden State Medical Supply, Inc.
- BelgiumDimethyl Fumarate AB 120 mgAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Balfumon, Dimethyl Fumarat Zentiva
- Belgium · Dimethyl Fumarate, Dimethyl Fumarate Ab
- Bulgaria · Arbicen, Dimethyl Fumarate Msn
- Cyprus · Dimethyl Fumarate Ebewe, Dimethyl Fumarate Hemopharm
- Czechia · Adifemu, Cohiber
- Germany · Dimethyl Fumarate Piramal, Dimethylfumarat 089pharm
- Denmark · Dimethyl Fumarate 1a Farma, Dimethyl Fumarate G.L. Pharma
- Estonia · Dimethyl Fumarate, Dimethyl Fumarate Aliud
- Spain · Dimforda, Fumarato De Dimetilo Aurovitas
- Finland · Dimethyl Fumarate, Dimethyl Fumarate 1a Farma
- France · Dimethyl Fumarate, Dimethyl Fumarate Arrow
- United Kingdom (Northern Ireland) · Dimethyl Fumarate, Dimethyl Fumarate G.L. Pharma
- Greece · Dimate, Dimethyl Fumarate Aenorasis
- Croatia · Dimethylfumarat Qilu, Dimetilfumarat
- Hungary · Adifemu, Arbicen
- Ireland · Dimethyl Fumarate, Dimethyl Fumarate Clonmel Healthcare
- Iceland · Dimethyl Fumarate, Dimethyl Fumarate 1a Farma
- Italy · Berbira, Dimetilfumarato
- Liechtenstein · Dimethyl Fumarate Accord, Dimethyl Fumarate Mylan
- Lithuania · Arbicen, Cohiber
- Luxembourg · Dimethyl Fumarate Eurogenerics
- Latvia · Cohiber, Dimethyl Fumarate
- Malta · Dimethyl Fumarate Clonmel, Dimethyl Fumarate Clonmel Healthcare
- Netherlands · Dimethyl Fumarate Aurobindo, Dimethylfumaraat Abdi
- Norway · Dimethyl Fumarate 1a Farma, Dimethyl Fumarate Accord
- Poland · Adifemu, Balfumon
- Portugal · Fumarato De Dimetilo Aurobindo, Fumarato De Dimetilo Farmoz
- Romania · Dimethyl Fumarate, Dimetil Fumarat
- Sweden · Dimethyl Fumarate, Dimethyl Fumarate 1a Farma
- Slovenia · Dimethyl Fumarate Msn, Dimetilfumarat Sandoz
- Slovakia · Adifemu, Arbicen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2d17bd7-34dc-498a-ac90-e00036814299 GET /v1/drugs/f2d17bd7-34dc-498a-ac90-e00036814299?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１２０ｍｇ１カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1190024M1028",
"category": "内用薬",
"price_yen": 2061.7,
"generic_name": "フマル酸ジメチル",
"product_name_jp": null,
"therapeutic_class": "1190",
"transitional_expiry": null
}See everything about フマル酸ジメチル.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.